Nexentis Technologies Inc. (NXTS)
Last updated: 2026-10-24 19:25:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Nexentis Technologies Inc. (NXTS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.53, with a market capitalization of $824.04K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.50 to $23.80. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$824.04K | |
$0.57 | |
$23.80 | |
$0.50 | |
$0.57 | |
29.03K | |
361.59K | |
-- | |
$23.80 | |
$0.50 | |
-- | |
-- |
Nexentis Technologies Inc. (NXTS) Latest Closing Stock Price
Nexentis Technologies Inc. (NXTS) last closed at $0.57 as of 2026-10-23 23:53:00, unchanged from the previous close of $0.57.
During the latest regular trading session, NXTS traded between $0.50 and $23.80, with a volume of 29.03K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Nexentis Technologies Inc. (NXTS) 7-Day Stock Price Change
Over the past seven days, Nexentis Technologies Inc. (NXTS) moved from $0.68 to $0.53, representing a decline of 21.85% ($0.15).
The stock traded between $0.50 and $0.71 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 73.81 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
NXTS 52-Week Price Position
Position in Range: 0.1%
NXTS is currently trading at $0.53, placing it 0.1% of the way from its 52-week low of $0.50 to its 52-week high of $23.80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Nexentis Technologies Inc. (NXTS)?
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
Nexentis Technologies Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 9 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Nexentis Technologies Inc. (NXTS) Stock on MEXC
Eligible investors can buy real shares of Nexentis Technologies Inc. (NXTS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Nexentis Technologies Inc. (NXTS) stock price today?
2.Is NXTS stock going up or down today?
3.What is NXTS pre-market price?
4.What is NXTS after-hours price?
5.Is NXTS stock trading now?
6.Where does NXTS sit relative to its 52-week high and low?
7.What sector is Nexentis Technologies Inc. in?
8.What is Nexentis Technologies Inc.'s market capitalization and where is it listed?
9.How is NXTS valued in terms of P/E ratio and EPS?
10.Does Nexentis Technologies Inc. pay a dividend?
Explore More US Stocks
Search Stocks
NXTS Stock Calculator
Estimate the value between NXTS shares and USD.
NXTS Shares to USD
1.00 NXTS shares = 0.533 USD
Calculations are estimates based on the latest available price and are for reference only.


